Evidence map›Paper›PMID 38519499›Full record

ArticleNature communications2024

Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance.

Pablo Laborda, Signe Lolle, Sara Hernando-Amado, Manuel Alcalde-Rico, Kasper Aanæs, José Luis Martínez, Søren Molin, Helle Krogh Johansen

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Frontiers in bioinformatics · 2026
    Review
  7. Host-pathogen-immune interactions in an air-liquid interface airway model.Frontiers in cellular and infection microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. OvercomingAntibiotics (Basel, Switzerland) · 2025
    Review
  14. Article
  15. Anaerobiosis and Mutations Can Reduce Susceptibility ofPathogens (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pablo LabordaDepartment of Clinical Microbiology 9301, Rigshospitalet, Copenhagen, Denmark. palama@biosustain.dtu.dk.ORCID http://orcid.org/0000-0001-8281-7900
Signe LolleDepartment of Clinical Microbiology 9301, Rigshospitalet, Copenhagen, Denmark.
Sara Hernando-AmadoCentro Nacional de Biotecnología, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0001-5822-4996
Manuel Alcalde-RicoCentro Nacional de Biotecnología, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0002-1987-4600
Kasper AanæsDepartment of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen, Denmark.
José Luis MartínezCentro Nacional de Biotecnología, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0001-8813-7607
Søren MolinThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.
Helle Krogh JohansenDepartment of Clinical Microbiology 9301, Rigshospitalet, Copenhagen, Denmark. hkj@biosustain.dtu.dk.ORCID http://orcid.org/0000-0003-0268-3717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in mexZ, encoding a negative regulator of the expression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialPseudomonas InfectionsBacterial ProteinsHumansMicrobial Sensitivity TestsMutationPseudomonas aeruginosaTobramycinAnti-Bacterial AgentsBacterial ProteinsMexZ protein, Pseudomonas aeruginosaTobramycin

Identifiers

PMID38519499
PMCPMC10959964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.